Common use of TO CONSULTING AGREEMENT Clause in Contracts

TO CONSULTING AGREEMENT. This Amendment No. 5 to Consulting Agreement (“Amendment No. 4”) is made as of February 1, 2021, by and between Elicio Therapeutics Inc., formerly operating under the name of Vedantra Pharmaceuticals, Inc., with a principal place of business being One Xxxxxxx Square, Building 1400 West, Suite 14303, Xxxxxxxxx, XX 00000 (“Company”) and Xxxxxxxx Advisors, LLC, a Massachusetts limited liability company, with a principal place of business being 00 Xxxxxx Xxxx, Xxxxxxxxxxxx, XX 00000 (“Xxxxxxxx”). Capitalized terms used but not defined herein shall have the respective meaning set forth in the Consulting Agreement by and between Xxxxxxxx and the Company dated as of March 13, 2013 (“Agreement”).

TO CONSULTING AGREEMENT. This Amendment No. 5 to Consulting Agreement (“Amendment No. 4”) is made as of February 1, 2021, by and between Elicio Therapeutics Inc., formerly operating under the name of Vedantra Pharmaceuticals, Inc., with a principal place of business being One Oxx Xxxxxxx SquareXxxxxx, Building 1400 West, Suite 14303, XxxxxxxxxCambridge, XX 00000 MA 02139 (“Company”) and Xxxxxxxx Dxxxxxxx Advisors, LLC, a Massachusetts limited liability company, with a principal place of business being 00 90 Xxxxxx Xxxx, Xxxxxxxxxxxx, XX 00000 (“XxxxxxxxDxxxxxxx”). Capitalized terms used but not defined herein shall have the respective meaning set forth in the Consulting Agreement by and between Xxxxxxxx Dxxxxxxx and the Company dated as of March 13, 2013 (“Agreement”).

TO CONSULTING AGREEMENT. This Amendment No. 5 4 to Consulting Agreement (“Amendment No. 4”) is made as of February 1December 18, 20212020, by and between Elicio Therapeutics Inc., formerly operating under the name of Vedantra Pharmaceuticals, Inc., with a principal place of business being One Xxxxxxx Square, Building 1400 West, Suite 14303, Xxxxxxxxx, XX 00000 (“Company”) and Xxxxxxxx Advisors, LLC, a Massachusetts limited liability company, with a principal place of business being 00 Xxxxxx Xxxx, Xxxxxxxxxxxx, XX 00000 (“Xxxxxxxx”). Capitalized terms used but not defined herein shall have the respective meaning set forth in the Consulting Agreement by and between Xxxxxxxx and the Company dated as of March 13, 2013 (“Agreement”).

TO CONSULTING AGREEMENT. This Amendment No. 5 4 to Consulting Agreement (“Amendment No. 4”) is made as of February 1December 18, 20212020, by and between Elicio Therapeutics Inc., formerly operating under the name of Vedantra Pharmaceuticals, Inc., with a principal place of business being One Oxx Xxxxxxx SquareXxxxxx, Building 1400 West, Suite 14303, XxxxxxxxxCambridge, XX 00000 MA 02139 (“Company”) and Xxxxxxxx Dxxxxxxx Advisors, LLC, a Massachusetts limited liability company, with a principal place of business being 00 90 Xxxxxx Xxxx, Xxxxxxxxxxxx, XX 00000 (“XxxxxxxxDxxxxxxx”). Capitalized terms used but not defined herein shall have the respective meaning set forth in the Consulting Agreement by and between Xxxxxxxx Dxxxxxxx and the Company dated as of March 13, 2013 (“Agreement”).